Phase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD) — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(9 sites)
United States
Retina Vitreous Associates of Florida - Saint Petersburg, St. Petersburg, Florida Ophthalmic Consultants of Boston, Boston, Massachusetts Retina Consultants of Texas, Katy, Texas Wagner Kapoor Research Institute, Norfolk, Virginia China
The Second Hospital Of Anhui Medical University, Hefei, Anhui Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang Eye Hospital, WMU (Zhejiang Eye Hospital), Wenzhou, Zhejiang Beijing Hospital, Beijing Peking Union Medical College Hospital, Beijing Last updated January 2025